• Latest Posts

The Biggest Biotech News of 2017: What Happened This Year?

Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic

In Depth 13 Jun 2017

Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?

Interview 20 Apr 2017

Which EU Immuno-Oncology Company are you Cheering for?

How is Biotech Transforming Pharma’s R&D Model?

Interview 16 Mar 2017

“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”

What are the Best Countries to Recruit Biotech Talents in 2017?

Infographics 13 Feb 2017

Infographic: What’s in Europe’s Immuno-oncology Pipeline?

UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan